associated with high symptom distress, poorer QoL, and increased psychological symptom burden. The patients analyzed were part of a randomized controlled trial of adherence and symptom management comparing a smartphone mobile application intervention versus
Search Results
Orally Administered Cancer Therapy: Breaking Down Barriers to Adherence and Quality of Life
Julia C. Shih and Anthony J. Olszanski
Edmonton Symptom Assessment Scale and Clinical Characteristics Associated With Cannabinoid Use in Oncology Supportive Care Outpatients
Young D. Chang, Jae-Woo Jung, Ritika Oberoi-Jassal, Jongphil Kim, Sahana Rajasekhara, Meghan Haas, Joshua Smith, Vijay Desai, Kristine A. Donovan, and Diane Portman
, including chronic pain, spasticity, seizures, anorexia, nausea, and glaucoma. 2 – 4 In addition, marijuana has been highlighted as a potential immune-modulating or anticancer agent. 5 Given the symptom burden reported by patients in the oncology outpatient
NCCN Debuts New Guidelines for Myeloproliferative Neoplasms
Ruben A. Mesa
are different for them,” he advised. Patient Assessment For patient assessment, the NCCN MPN Panel drew from the WHO diagnostic criteria. For quantifying the symptom burden, it incorporated the MPN Symptom Assessment Form. For prognosis
Highlights of the NCCN Oncology Research Program
, emotional distress, and poor QoL. To help address these concerns, national guidelines now recommend that patients with advanced cancer and those with high symptom burden receive early palliative care integrated with oncology care from the time of diagnosis
The Integration of Early Palliative Care With Oncology Care: The Time Has Come for a New Tradition
Jessica R. Bauman and Jennifer S. Temel
List the most common barriers to the integration of PC into cancer care Discuss the future directions of early PC models in oncology care P atients with advanced, incurable cancers often experience a tremendous symptom burden, emotional
EHR-Integrated Patient-Reported Outcomes in Ambulatory Oncology: A Critical Opportunity for Timely and Targeted Palliative Care
Patricia I. Moreno, Frank J. Penedo, Felicia M. Knaul, Carina Oltmann, Michael T. Huber, and Mariana Khawand-Azoulai
of PROs in ambulatory oncology improves patient–provider communication, satisfaction with care, health-related quality of life (HRQoL), symptom burden, and clinical outcomes. 1 – 4 As a result, there has been a significant interest in both
Interferons as the First Choice of Cytoreduction in Essential Thrombocythemia and Polycythemia Vera
Joan How and Gabriela Hobbs
hematologic and molecular responses and similar rates of adverse events. 26 However, interferon’s distinct adverse effect profile will limit its use in certain patient populations. However, symptom burden remains substantial even among responders. In a post
Mitigating the Risk of Aberrant Use of Opioids in Patients With Cancer Pain
Marcin Chwistek
? In short, COMM has a very high false-positive rate in patients treated with opioids for cancer pain. This is not surprising. It is easy to notice that the high score may result from high distress and symptom burden of cancer-related symptoms in
Early Implementation of Palliative Care Can Improve Patient Outcomes
Paul A. Glare
and patients with newly diagnosed advanced cancer often have a high symptom burden. 14 With the growing incidence and prevalence of cancer and the number of patients who live with the consequences of the disease and treatment, a comprehensive but
Palliative Care: Who is Responsible?
Amanda M. Rosenblum and Martin R. Chasen
interdisciplinary specialist palliative care in reducing symptom burden and detecting distress in patients with high intensity scores. Their team consistently used 2 validated tools at patient encounters: the Edmonton Symptom Assessment System (ESAS) and the
